Background: This is the first longitudinal study to assess regional cerebral blood flow (rCBF)
changes during the progression from normal control (NC) through mild cognitive impairment …

Background: Cross-sectional studies have shown lower cerebral blood flow (CBF) in
Alzheimer's disease (AD), but longitudinal CBF changes in AD are still unknown. Objective …

Background: Reliable cerebral blood flow (CBF) biomarkers using a noninvasive imaging
technique are sought to facilitate early diagnosis and intervention in early Alzheimer's …

Background With the disappointing outcomes of clinical trials on patients with Alzheimer's
disease or mild cognitive impairment (MCI), there is increasing attention to understanding …

Alzheimer's disease (AD) depicts dynamic changes in regional brain function from early
stages of the disease. Arterial spin labeling‐(ASL‐) based MRI methods have been applied …

Cerebral blood flow (CBF) measured with arterial spin labelling (ASL) magnetic resonance
imaging (MRI) reflects cerebral perfusion, related to metabolism, and arterial transit time …

Purpose To compare quantitative cerebral blood flow (CBF) values in patients with
Alzheimer disease (AD), patients with mild cognitive impairment (MCI), and subjects with …

We examined differences in cerebral blood flow (CBF) measured by Arterial Spin Labeled
perfusion MRI (ASL MRI) across the continuum from cognitively normal (CN) older adults to …

Objectives To investigate arterial spin-labelling (ASL) cerebral blood flow (CBF) changes in
predementia stages of Alzheimer's disease (AD). Methods Data were obtained from 177 …

Objectives: Subjective cognitive decline (SCD), or self-reported cognitive decline despite
normal neuropsychological test performance, is a risk factor for objective cognitive decline …